Literature DB >> 22748847

[Primary, non-metastatic gastrointestinal stromal tumour surgery: results of the GRISK study].

Vicente Artigas Raventós1, Antonio López Pousa, Luis Ortega Medina, Alvaro Díaz de Liaño Argüelles, Juan Ángel Fernández Hernández, José Luis Lucena de la Poza.   

Abstract

INTRODUCTION AND
OBJECTIVES: Radical surgery is the standard treatment for localised gastrointestinal stromal tumours (GIST). A series of primary GIST, their treatment and pre-established risk of recurrence after their follow-up is evaluated.
MATERIAL AND METHODS: A retrospective, descriptive and multicentre study was conducted on primary, non-metastatic GIST operated on between June 2007 and December 2008. The variables of greater relevance were analysed, including, location, size, mitotic index, and NHI and AFIP recurrence prognostic criteria, and their correlation with the disease-free survival (DFS) of the patients.
RESULTS: The series included 141 patients with a mean age of 65 years. The most frequent GIST location was in the stomach (70.8%) and small intestine (22.9%), and with a mean tumour size of 6.7 cm (0.5-35 cm). The surgery was R0 in 97.2% of cases (laparoscopic approach, 21.5%). The distribution according to NHI/Flescher criteria was, high (31.95%), and intermediate (26.4%), and according to AFIP/Miettinen criteria it was, high (22.9%) and intermediate (12.5%). After a mean follow-up of 20.3 months, there was a 7.1% (10 cases) recurrence, with only 2 cases belonging to the group with a «low risk» using the NHI and AFIP prognostic criteria. The DFS at one year was 95.5% and 91.5% at 2 years.
CONCLUSIONS: The series showed a high DFS and a good correlation with both the Flescher and the Miettinen criteria. However, the risk of recurrence varied according to the AFIP criteria (intermediate/high, 58.3%), or the AFIP criteria (intermediate/high, 35.4%) which included the tumour location. For this reason, we consider these latter criteria as the most adequate for assessing the prognostic risk of GIST recurrence.
Copyright © 2011 AEC. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22748847     DOI: 10.1016/j.ciresp.2012.05.002

Source DB:  PubMed          Journal:  Cir Esp        ISSN: 0009-739X            Impact factor:   1.653


  2 in total

1.  [Gastrointestinal stromal tumor of the ileum with metastatic relapse developed in the mesentery].

Authors:  Fanomezantsoa Raherinantenaina; Fanjandrainy Rasoaherinomenjanahary; Andriamampionona Tsitohery Francine; Andrianisa Hoby Rambel; Harinirina Yoël Honora Rantomalala; Luc Hervé Samison; Hery Nirina Rakoto Ratsimba
Journal:  Pan Afr Med J       Date:  2014-05-05

2.  Laparoscopic resection of large gastric gastrointestinal stromal tumours.

Authors:  Sebastian Smolarek; Eoghan Pomeroy; Fiona Kinnarney; Mayilone Arumugasamy
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-12-16       Impact factor: 1.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.